Penn Medicine Abramson Cancer Center

Event

Cellicon Valley '25: The Future of Cell and Gene Therapies

presented by Penn Medicine Abramson Cancer Center

2 others would like to attend.

Register Now

Notification icon Wednesday, April 30, 2025 8 AM - Friday, May 2, 2025 4 PM US/Eastern

Location Icon Irvine Auditorium, 3401 Spruce Street, Philadelphia, PA 19104

Event info

Overview

Penn Medicine and Children's Hospital of Philadelphia remain at the forefront of cell and gene therapy, solidifying Philadelphia's status as "Cellicon Valley." The University of Pennsylvania continues to lead in CAR-T cell research, reflecting its ongoing commitment to innovation in this field, particularly through the pioneering work of the Center for Cellular Immunotherapies.  

While CAR T-cell therapy has already revolutionized cancer treatment, the field continues to evolve rapidly. This activity provides a unique opportunity to interact with world-renowned experts in CAR T-cell therapy for cancer, hematologic disorders and autoimmune diseases. 

Clinicians will discover cutting-edge strategies to optimize patient care and overcome challenges in the field. Researchers will delve into the scientific and technical breakthroughs shaping the future of this revolutionary treatment. Business leaders will gain a comprehensive understanding of the CAR T-cell therapy landscape with a focus on commercial partnering, product development and entrepreneurship.

Learning Objectives

Upon completion of this symposium, participants should be able to:

  • Evaluate barriers to equitable CAR-T cell therapy access and evaluate how philanthropic initiatives can improve access.
  • Summarize recent advances in CAR T-cell therapy, including applications for autoimmunity and immunoregulation.
  • Discuss the challenges and future directions of translating stem cell research into clinical practice.
  • Evaluate the therapeutic potential of stem cell-based interventions.
  • Explain how gene editing technologies are used in stem cell engineering.
  • Review how mRNA technology is transforming cell and gene therapies.
  • Identify novel targets and strategies for overcoming treatment resistance in solid tumors.
  • Analyze the risks and benefits of cell and gene therapies, including clinical and long-term outcomes.
  • Explore the career paths and influence of successful women leaders in STEM.
  • Assess the cost-effectiveness of cell and gene therapies within the context of healthcare economics.
  • Examine strategies for successful technology transfer and collaboration between academia and industry.
  • Define the role of industry partnerships and regulatory pathways in advanced therapy development.
  • Recognize effective leadership strategies in the cell and gene therapy field.
  • Analyze the challenges and opportunities in commercializing cell and gene therapies.
  • Outline the process of translating advanced therapies from research to clinical practice and commercialization.

Target Audience

These activities are intended for both adult and pediatric hematologist-oncologists, medical oncologists, hematologists, hematopathologists, immunologists, immunobiologists, transfusion medicine, researchers, pharmacists, fellows, nurses, nurse practitioners, physician assistants, industry professionals and other healthcare professionals interested in the latest advances in cell and gene therapy. Additionally, patients and their caregivers, family members, advocates and members of the public who may benefit from understanding current innovative approaches to gene and cell therapy are also invited.

For more information please visit the official event page.

2 others would like to attend.

Register Now


Comments 0
Login to view comments. Click here to Login